Challenge --Life science companies are under increasing pressure from health insurers and policymakers to differentiate their therapies against cut-price competitors. The solution is often to create broader solutions to a disease, aligning existing therapies with other types of interventions that can achieve superior medical and economic outcomes.
Activities -- New Markets helped to scope the range of potential disease-state solutions in the client's key therapeutic areas. It also met with a range of start-ups and more established firms that could provide excellent complements to existing offerings, and it assisted in designing business and go-to-market models that support the integrated approaches. Results -- The company has now forged partnerships with several external firms in a variety of areas, and it is bolstering internal capabilities in a strategic field.